Continuing controversy in the management of concomitant coronary and carotid disease: an overview

S K Das1, T D Brow, J Pepper

  • 1Department of Surgery, Royal Brompton Hospital, London, UK. sarojdas@doctors.org.uk

Insights

Managing concomitant coronary artery disease and carotid artery stenosis (CAS) requires careful consideration of stroke risk factors. Prior staged procedures may reduce stroke incidence during coronary artery bypass grafting (CABG) compared to combined approaches.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Vascular Surgery

Background:

  • Concomitant coronary artery disease and carotid artery stenosis (CAS) pose significant risks during cardiac surgery.
  • Stroke is a major complication of coronary artery bypass grafting (CABG), with CAS being a contributing factor.

Purpose of the Study:

  • To analyze risk factors, pathogenesis, and management strategies for stroke in patients undergoing CABG with concomitant CAS.
  • To compare the outcomes of four management strategies: CABG with CAS, combined endarterectomy and CABG (CE+CABG), reverse staged (CABG+CE<3 months), and prior staged (CE+CABG<3 months).

Main Methods:

  • A literature search was conducted to establish a reference database.
  • Outcomes were assessed by 30-day permanent stroke and mortality rates for each strategy.
  • Data were analyzed comparatively using P values, odds ratios, and confidence limits.

Main Results:

  • 33 stroke risk factors at CABG were identified, including ascending aortic atheroma and peripheral vascular disease.
  • Stroke risk increased with higher-grade CAS.
  • Prior staged procedures showed a significantly lower mean stroke rate (1.5%) compared to combined procedures (3.9%).
  • Total risk (stroke + mortality) was lowest in the prior staged (7.4%) and reverse staged (7.2%) groups.

Conclusions:

  • Stroke during CABG is multifactorial, with embolism implicated more than flow limitation in high-grade CAS.
  • While no single strategy is definitively superior due to a lack of randomized trials, prior staging appears beneficial for carefully selected patients.
  • Prior staging is recommended for patients without severe cardiac disease, while combined procedures may be suitable for others; reverse staging requires further evaluation.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...